Scpharmaceuticals Alpha and Beta Analysis
| SCPHDelisted Stock | USD 5.67 0.01 0.18% |
This module allows you to check different measures of market premium (i.e., alpha and beta) for all equities such as Scpharmaceuticals. It also helps investors analyze the systematic and unsystematic risks associated with investing in Scpharmaceuticals over a specified time horizon. Remember, high Scpharmaceuticals' alpha is almost always a sign of good performance; however, a high beta will depend on investors' risk tolerance level and may signal increased volatility and potential future overvaluation. Key technical indicators related to Scpharmaceuticals' market risk premium analysis include:
Beta 0.12 | Alpha 0.59 | Risk 0.0 | Sharpe Ratio 0.0 | Expected Return 0.0 |
Alpha is a measure of relative performance on a risk-adjusted basis, while beta measures volatility against the benchmark. The goal is to know if an investor is being compensated for the volatility risk taken. The return on investment might be better than its reference but still not compensate for the assumption of the risk.
Scpharmaceuticals |
Scpharmaceuticals Market Premiums
Investors always prefer to have the highest possible return on investment, coupled with the lowest possible volatility. Scpharmaceuticals market risk premium is the additional return an investor will receive from holding Scpharmaceuticals long position in a well-diversified portfolio. The market premium is part of the Capital Asset Pricing Model (CAPM), which most analysts and investors use to calculate the acceptable rate of return on investment in Scpharmaceuticals. At the center of the CAPM is the concept of risk and reward, which is usually communicated by investors using alpha and beta measures. Alpha and beta are two of the key measurements used to evaluate Scpharmaceuticals' performance over market.| α | 0.59 | β | 0.12 |
Scpharmaceuticals Fundamentals Vs Peers
Comparing Scpharmaceuticals' fundamentals to the average values of its peers is one of the most widely used and accepted methods of equity analyses. It helps to analyze Scpharmaceuticals' direct or indirect competition across all of the common fundamentals between Scpharmaceuticals and the related equities. This way, we can detect undervalued stocks with similar characteristics as Scpharmaceuticals or determine the stocks which would be an excellent addition to an existing portfolio. Peer analysis of Scpharmaceuticals' fundamental indicators could also be used in its relative valuation, which is a method of valuing Scpharmaceuticals by comparing valuation metrics with those of similar companies.
| Better Than Average | Worse Than Average | Compare Scpharmaceuticals to competition |
| Fundamentals | Scpharmaceuticals | Peer Average |
| Return On Equity | -9.34 | -0.31 |
| Return On Asset | -0.57 | -0.14 |
| Profit Margin | (1.84) % | (1.27) % |
| Operating Margin | (0.89) % | (5.51) % |
| Current Valuation | 315.46 M | 16.62 B |
| Shares Outstanding | 53.68 M | 571.82 M |
| Shares Owned By Insiders | 5.97 % | 10.09 % |
Scpharmaceuticals Opportunities
Scpharmaceuticals Return and Market Media
The Stock received some media coverage during the period. Price Growth (%) |
| Timeline |
1 | SHAREHOLDER INVESTIGATION Halper Sadeh LLC Investigates BRY, SCPH, WKHS on Behalf of Shareholders | 09/22/2025 |
2 | Is scPharmaceuticals Inc. stock trading at attractive multiples - Quarterly Performance Summary Reliable Price Breakout Signals - newser.com | 09/29/2025 |
About Scpharmaceuticals Beta and Alpha
For many years both, Alpha and Beta indicators are used by professional money managers as critical performance measurement tools across virtually all financial instruments including Scpharmaceuticals or other delisted stocks. Alpha measures the amount that position in Scpharmaceuticals has returned in comparison to a selected market index or another relevant benchmark. In other words, Alpha is the excess return on an investment relative to the performance of your selected benchmark. Beta, on the other hand, measures the relative risk of your investment.
Scpharmaceuticals Upcoming Company Events
As portrayed in its financial statements, the presentation of Scpharmaceuticals' financial position is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Scpharmaceuticals' leadership is honest, while the outside auditors are strict and uncompromising. Whatever the case, investors should always follow all of Scpharmaceuticals' public filing events to personally review all filings and be reasonable and skeptical to interpret all of the financial statements of Scpharmaceuticals. Please utilize our Beneish M Score to check the likelihood of Scpharmaceuticals' management manipulating its earnings.
| 27th of March 2024 Upcoming Quarterly Report | View | |
| 8th of May 2024 Next Financial Report | View | |
| 31st of December 2023 Next Fiscal Quarter End | View | |
| 27th of March 2024 Next Fiscal Year End | View | |
| 30th of September 2023 Last Quarter Report | View | |
| 31st of December 2022 Last Financial Announcement | View |
Build Portfolio with Scpharmaceuticals
Your optimized portfolios are the building block of your wealth. We provide an intuitive interface to determine which securities in a portfolio should be removed or rebalanced to achieve better diversification, find the right mix of securities that minimizes portfolio risk for a given return, or maximize portfolio expected return for a given risk level.Build Diversified Portfolios
Align your risk with return expectations
Check out World Market Map to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as various price indices. You can also try the Fundamental Analysis module to view fundamental data based on most recent published financial statements.
Other Consideration for investing in Scpharmaceuticals Stock
If you are still planning to invest in Scpharmaceuticals check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Scpharmaceuticals' history and understand the potential risks before investing.
| Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
| USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA | |
| ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments | |
| Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
| Transaction History View history of all your transactions and understand their impact on performance | |
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Money Managers Screen money managers from public funds and ETFs managed around the world | |
| Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing | |
| Economic Indicators Top statistical indicators that provide insights into how an economy is performing |